Cargando…

Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice

This article considers the use of pretest probability in non-small cell lung cancer (NSCLC) and how its use in EGFR testing has helped establish clinical guidelines on selecting patients for EGFR testing. With an ever-increasing number of molecular abnormalities being identified and often limited ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Petra, Leighl, Natasha B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455881/ https://www.ncbi.nlm.nih.gov/pubmed/28607579 http://dx.doi.org/10.1177/1758834017704329

Ejemplares similares

Correlation between the clinical pretest probability score and the lung ventilation and perfusion scan probability
por: Bhoobalan, Shanmugasundaram, et al.
Publicado: (2013)

Pretest probability assessment derived from attribute matching
por: Kline, Jeffrey A, et al.
Publicado: (2005)

90: METHODS OF ESTIMATING PRETEST PROBABILITY IN PRIMARY CARE SETTING
por: Pezeshki, Mohammad Zakaria, et al.
Publicado: (2017)

Ruling out Pulmonary Embolism in Patients with High Pretest Probability
por: Akhter, Murtaza, et al.
Publicado: (2018)

A predictive model to estimate the pretest probability of metastasis in patients with osteosarcoma
por: Wang, Sisheng, et al.
Publicado: (2017)

Renal angina: concept and development of pretest probability assessment in acute kidney injury
por: Chawla, Lakhmir S, et al.
Publicado: (2015)

Why pretest probability matters when we do point‐of‐care ultrasound
por: Duggan, Nicole M., et al.
Publicado: (2020)

Data sources and methods used to determine pretest probabilities in a cohort of Cochrane diagnostic test accuracy reviews
por: Oerbekke, Michiel S., et al.
Publicado: (2020)

Derivation and Validation of a 4-Level Clinical Pretest Probability Score for Suspected Pulmonary Embolism to Safely Decrease Imaging Testing
por: Roy, Pierre-Marie, et al.
Publicado: (2021)

Tips for Teachers of Evidence-based Medicine: Clinical Prediction Rules (CPRs) and Estimating Pretest Probability
por: McGinn, Thomas, et al.
Publicado: (2008)

Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab
por: Giannitto, Caterina, et al.
Publicado: (2020)

Influence of Changes in Pretest-probability for Chronic Coronary Syndromes on Diagnostic Performance of Dobutamine Stress Echocardiography
por: Son, Jang-Won
Publicado: (2021)

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
por: Korpanty, Grzegorz J., et al.
Publicado: (2014)

Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents
por: Owaidah, Tarek, et al.
Publicado: (2014)

The safety, efficacy and cost-effectiveness of stress echocardiography in patients with high pretest probability of coronary artery disease
por: Papachristidis, Alexandros, et al.
Publicado: (2017)

Comparison of Brock University, Mayo Clinic and Herder models for pretest probability of cancer in solid pulmonary nodules
por: Susam, Seher, et al.
Publicado: (2022)

The Effect of Pretest Exercise on Baseline Computerized Neurocognitive Test Scores
por: Pawlukiewicz, Alec, et al.
Publicado: (2017)

Deep Venous Thrombosis in a Patient with a Moderate Pretest Probability and a Negative D-Dimer Test: A Review of the Diagnostic Algorithms
por: Al-Khafaji, Rasha A, et al.
Publicado: (2020)

Analysis of pretest-posttest designs /
por: Bonate, Peter L.
Publicado: (2000)

PCR colorimetric dot-blot assay and clinical pretest probability for diagnosis of Pulmonary Tuberculosis in Smear-Negative patients
por: Scherer, Luciene Cardoso, et al.
Publicado: (2007)

The Diagnostic Efficacy of Age-Adjusted D-Dimer Cutoff Value and Pretest Probability Scores for Deep Venous Thrombosis
por: Li, Junxun, et al.
Publicado: (2019)

Rethinking the “Pan-Culture”: Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia
por: Albin, Owen R, et al.
Publicado: (2022)

A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
por: Tripathi, Raghav, et al.
Publicado: (2023)

Ancillary Testing in Lung Cancer Diagnosis
por: Dubinski, William, et al.
Publicado: (2012)

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
por: Barnes, Tristan A., et al.
Publicado: (2017)

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine
por: Soldera, Sara Victoria, et al.
Publicado: (2017)

Relationship Between Medical Questionnaire and Influenza Rapid Test Positivity: Subjective Pretest Probability, “I Think I Have Influenza,” Contributes to the Positivity Rate
por: Katsuki, Masahito, et al.
Publicado: (2021)

Comparison of risk assessment strategies incorporating coronary artery calcium score with estimation of pretest probability to defer cardiovascular testing in patients with stable chest pain
por: Meng, Jia, et al.
Publicado: (2023)

The benefits of impossible tests: Assessing the role of error-correction in the pretesting effect
por: Seabrooke, Tina, et al.
Publicado: (2021)

2352. Clinician Assessment of Pretest Probability for Clostridioides difficile Infection and Disease Severity While Using Multiplex, Syndromic Molecular Panel in Patients Presenting with Diarrhea
por: Throneberry, S Kyle, et al.
Publicado: (2019)

Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York
por: Samhouri, Yazan, et al.
Publicado: (2016)

RE: A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
por: Prieto, Peter A., et al.
Publicado: (2023)

Emerging therapies for non-small cell lung cancer
por: Zhang, Chao, et al.
Publicado: (2019)

Incidental Findings: The Importance of Pretest Counseling
por: Buchtel, Kathryn M., et al.
Publicado: (2015)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
por: Puri, Sonam, et al.
Publicado: (2020)

Pretest setup installation of the METU-DBL project to perform space radiation tests
por: Demirkoz, M Bilge, et al.
Publicado: (2017)

Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada
por: Perdrizet, Kirstin, et al.
Publicado: (2021)

Comparison of NICE and ESC proposed strategies on new onset chest pain and the contemporary clinical utility of pretest probability risk score
por: Papachristidis, Alexandros, et al.
Publicado: (2020)

Optimizing the Efficacy of Learning Objectives through Pretests
por: Sana, Faria, et al.
Publicado: (2020)

Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
por: Patel, Yuti P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lgg6alcu82ucu5hdfo4mq8j0di